Log In
Or create an account ->
Imperial Library
Home
About
News
Upload
Forum
Help
Login/SignUp
Index
Cover
Contents
Title page
Copyright page
Contributors
Foreword
Preface
1: Mechanics of the Cardiovascular System
Overview
Basic heart anatomy
The cardiac cycle
Cardiac output
Conclusion
2: Regulation of Cardiac and Vascular function
Overview
Central nervous system regulation of the cardiovascular system
Vasomotor control
Baroreceptors
Chemoreceptors
Humoral control
Electrolytes
Conclusion
3: Cardiac Electrophysiology
Overview
Cardiac cells
The action potential
The action potential in non-pacemaker cells
The cardiac conduction system
The electrocardiogram
Conclusion
4: The Coronary Circulation
Overview
The coronary circulation
The left main coronary artery
The LAD artery
The LCX or CX artery
The right coronary artery
Collateral circulation
Microvascular circulation
Coronary venous circulation
5: Risk Factors for Cardiovascular Disease
Overview
Classification of risk factors for CVD
Biomedical risk factors
Behavioural risk factors
Psychosocial risk factors
Conclusion
6: Populations at Risk
Overview
Risk factors for CVD
Clarifying risk
Risk assessment tools
Populations at increased risk
Targeting treatment
Using what we know
Conclusion
7: Evidence-Based Practice
Overview
The need for change
Evidence-based practice
Barriers to the evidence
Conclusion
8: Ethics of Research in Acute Cardiac Care
Overview
Evidence-based medicine and clinical trials
Informed consent for trial participation
What is an ethical dilemma?
Genetic research
Considering an offer for the unit to participate in a clinical trial
Ethical issues in marketing and pricing of new pharmaceutical agents
Conclusion
9: Cardiovascular Assessment
Overview
Health history
Physical examination
Conclusion
10: Electrocardiogram Interpretation
Overview
Normal sequence of depolarisation and repolarisation
Theoretical basis of electrocardiography
Determining the cardiac axis
Determination of heart rate and electrocardiographic intervals
Chamber enlargement
Bundle branch block
ECG changes related to myocardial ischaemia and infarction
Obtaining a 12-lead ECG
Conclusion
11: Cardiac Monitoring
Overview
ECG monitoring systems and lead formats
Indications for arrhythmia monitoring
Nursing considerations in the care of the patient with ECG monitoring
12: Laboratory Tests
Overview
Generic laboratory tests
Electrolytes
Renal function
Glucose measurement
Lipid profiles
Complete blood examination
Clotting screen
Biochemical markers
Markers of myocardial necrosis
Cardiac natriuretic peptides
C-reactive protein
Conclusion
13: Diagnostic Procedures
Overview
Chest X-ray
Cardiac catheterisation (angiogram)
Echocardiography
Stress testing
Magnetic resonance imaging
Computerised tomography
Electrophysiology studies
Conclusion
14: Sudden Cardiac Death
Overview
Definitions
Burden of disease and risk factors for SCD
Sudden death in the young (including athletes)
Structural abnormalities
Cardiomyopathies and SCD
Genetic syndromes and SCD
Conclusion
15: Out-of-Hospital Cardiac Arrest and Automated External Defibrillation
Overview
Out-of-hospital cardiac arrest
Hazards to the victim and rescuer
Recognition of cardiac arrest and BLS
Automated external defibrillation
Conclusion
16: Ethical Issues in Resuscitation
Overview
Guiding ethical principles in resuscitation
Futility
Rights of the individual versus the needs of society
Patient perceptions of resuscitation
Introducing the DNR conversation
Witnessed resuscitation
Withdrawal of treatment
Organ donation
Training and research with the newly dead
17: Pathogenesis of Acute Coronary Syndromes
Overview
Acute coronary syndrome
Atherosclerosis
Endothelial dysfunction
Plaque disruption
Inflammation
Thrombosis
Vasoconstriction
Conclusion
18: Presentations of Acute Coronary Syndromes
Overview
Angina pectoris
Stable angina
The acute coronary syndromes
Global trends in ACS presentations
Clinical history in ACS
Physical examination in ACS patients
The 12-lead electrocardiogram in ACS
Cardiac markers in ACS
Clinical assessment and risk stratification in ACS
Conclusion
19: Risk Stratification in Acute Coronary Syndromes
Overview
Introduction
Risk stratification
Risk stratification guidelines
Risk scores
Chest pain units
Conclusion
20: Reducing Time to Treatment
Overview
Benefits of early reperfusion
Identifying and addressing delays
Conclusion
21: Reperfusion Strategies
Overview
Pathogenesis of STEMI
Principles of reperfusion strategies
Options for reperfusion
Strategies for reducing treatment time delays
Detecting and managing failed reperfusion
Preventing and detecting re-occlusion
Conclusion
22: Adjunct Pharmacological Agents in Acute Coronary Syndromes
Overview
Anti-ischaemic therapies
Antiplatelet and anticoagulant therapy
Inhibitors of the renin-angiotensin-aldosterone system
Statins
Conclusion
23: Arrhythmias
Overview
Basic electrophysiology
Mechanisms of arrhythmia generations
Cardiac monitoring
Rhythm interpretation
Determining the rhythm
Tachyarrhythmias
Asystole
Treatment of arrhythmias
Conclusion
24: In-Hospital Resuscitation
Overview
Introduction
Prevention: systems for identifying patients at risk of cardiac arrest
Early recognition and management of critically ill patients
In-hospital resuscitation
Working within your scope of practice
Audit and data collection
Conclusion
25: Acute Heart Failure
Overview
Introduction
Establishing the diagnosis
Management specifics
Refractory AHF
Dignity, communication and preventing complications: ‘back to basics’
Managing chronic heart failure better to reduce the need for re-hospitalisation
Conclusion
26: Convalescence
Overview
Introduction
Assessment and identification of patient needs
High risk groups
Promoting self-management in the convalescent phase
Particular concerns of spouses and family members
Accommodating convalescence and discharge planning following an acute cardiac event
Models of intervention to facilitate convalescence and secondary prevention
Nursing strategies to promote convalescence
Palliative care
Conclusion
27: Discharge Planning and Secondary Prevention
Overview
Discharge planning
Secondary prevention
Provision of secondary prevention
Components of secondary prevention
Cardio-protective drug therapy
Challenges in secondary prevention
Conclusion
Index
← Prev
Back
Next →
← Prev
Back
Next →